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ABSTRACT OF THE DISSERTATION 
Anterior Cruciate Ligament Elasticity and Force for Knee Flexion during the Menstrual 
Cycle in Oral Contraceptive Users and Non-oral Contraceptive Users 
 
by 
Haneul Lee 
Doctor of Sciecne, Graduate Program in Physical Therapy 
Loma Linda University, June 2013 
Dr. Jerrold Petrofsky, Chairperson 
 
 
Numerous studies have been conducted on changes of knee ligament laxity during 
the menstrual cycle (MC) since there are more injuries in certain phases.  Some 
researchers believe that since estrogen receptor β exists in ligaments and tendons in the 
knee, estrogen may modulate towards a state of laxity. However, increased tissue 
temperature also observed during the MC can predispose ligament and tendon laxness.  
 The number of women using oral contraceptive pills (OCP) has constantly 
increased in the United States.  This exogenous source of synthetic forms of steroid 
hormones prevents ovulation by maintaining more consistent daily hormone levels than 
occurs.  Since the estrogen receptor β exists on human connective tissue, OCP might have 
an impact on tendon and ligament synthesis, structure, and biomechanical properties.  
Therefore, the purpose of this study was to assess in women the relationship between 
Estradiol (E2) serum concentrations and tissue temperature during the MC and their 
combined effect on ACL elasticity, force to flex the knee (FFK), and knee flexion-
extension hysteresis (KFEH) in OCP users and non-OCP users. 
  
xiii 
Nineteen non-athletic young healthy females were divided into two groups; OCP users 
and non-OCP users.  E2 serum concentrations, ACL elasticity, FFK, and KFEH were 
assessed both at ambient temperature (22 °C) and after 38 °C warming of the leg to 
stabilize the normal temperature during the MC.  
 The result of this investigation showed that ACL elasticity was significantly lower 
and FFK and KFEH were significantly higher during ovulation compared to menstruation 
(p<0.05) but after 38 °C warming of the leg, there were no differences in KKF and KFEH 
in non-OCP users.  Also, ACL elasticity was significantly lower and FFK and KFEH were 
significantly higher OCP users than non-OCP users (p<0.05) at ambient temperature. But, 
no significant difference in FFK and FFEH between the two groups was found after 
warming to 38 °C.   
In conclusion, OCP users have more knee stiffness and effect of heat on FFK 
and KFEH when their legs were heated compared to non-OCP users.  In addition, 
ACL elasticity, FFK, and KFEH were affected not only by estrogen but tissue 
temperature during the menstrual cycle.   
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CHAPTER ONE 
INTRODUCTION 
 
Knee injuries occur most frequently in the anterior cruciate ligament (ACL); 80% 
of ACL injuries are non-contract ACL injuries 1.  Due to an increase in women’s sports 
participation, many researchers have looked at injuries occurring during sports activities 
and found that ACL injuries are more common in women compared to men who 
participate in the same activities 2-5.  The differences are commonly assumed to be 
differences in the anatomical, neuromuscular, behavior patterns, and hormones that make 
women more susceptible to ACL injuries than men 6,7.  Regarding hormonal influences, 
many previous investigators have examined the relationship between female reproductive 
hormones and structure and mechanical properties of the ACL 8-11.  The role of estrogen 
in possibly causing ACL injuries has recently been studied at the celluar level and the 
presence of 17- beta estradiiol receptors in the human ACL and muscle have been 
investigated 10-13.  The constant changes in estrogen concentration in blood during the 
menstrual cycle have been investigated to see if sex hormones are related to ligament 
laxity 10-13.  Human tendon, muscle, and ligament are composed of collagen fibers closely 
packed together. Due to the decrease of collagen formation and fibroblast proliferation 
with an increased estrogen serum concentration, the decreased collagen synthesis is 
believed to cause ligament laxness, and muscle and tendon flexibility all of which makes 
the ACL more susceptible to injuries 8, 10, 12.   
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Estradiol is the estrogen in women that is most commonly measured in young 
non-pregnant females 14.  Since most ACL injuries occur in young healthy women, most 
investigators have used estradiol as the major estrogen biomarker.  Estrodial serum 
concentration fluctuates throughout the menstrual cycle but in women who are taking oral 
contraceptive pills (OCP), it does not vary during the menstrual cycle 15,16.  Eighty two 
percent of sexually active women aged 15-44 have used the OCP in the United States and 
14% of women have used OCP for non-contraceptive purposes such as cycle regulation, 
treatment of dysmenorrhea and amenorrhea 17,18.  OCP consists of combined estrogen and 
progesterone as synthetic steroids and it plays a role in suppressing pituitary FSH and LH 
production and preventing ovulation from occurring 18,19.  This exogenous source of 
synthetic forms of the hormone prevents ovulation by maintaining more constant 
hormone levels 20.  Since estrogen is stabilized throughout the entire menstrual cycle, the 
response may be different in women on OPC.  Therefore, OCP may be another factor that 
affect on tendon and ligament synthesis, structure, and biomechanical properties.  
Martineau and colleagues have shown that OCP usesrs have less ACL laxity than non-
OCP users 21.   
However, there has been controversy as to the ACL laxity changes across the 
menstrual cycle. A systemic review on the effects of the menstrual cycle on anterior knee 
laxity by Zazulak and colleague showed that only three of the nine studies reported a 
significant difference on ACL laxity during the menstrual cycle 22.  Among 3 studies 
saying there was a significant difference in ACL elasticity during the menstrual cycle, the 
results are different.  Heitz and colleague showed that there was a greater knee laxity in 
the ovulation while Shultz and colleague found a greater knee laxity in the early follicular 
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phase 23,24.  Although Zazulak and colleague found limited evidence of the correlation 
between ACL laxity and sex hormones, they claimed that cycle phases might have an 
effect on anterior knee laxity. These researchers suggested that future investigators 
should consider the limitation in present methodologies that they had discovered 22.  They 
also point out confounding variables that might affect anterior knee elasticity during the 
menstrual cycle.  
  Temperature is one of the factors that affect elasticity in connective tissues, such 
that, an increase in tissue temperature, by doing warm-up exercises will increase muscle 
and tendon extensibility 25, 26.  In healthy young adults, normal core temperature is 
maintained between 36-37.5°C and it changes approximately 0.5°C throughout the day 27, 
28.  In women with a regular menstrual cycle, their core temperature fluctuates not only 
throughout the day but also during the menstrual cycle 29.  It is at a peak during the 
middle luteal phases while in the early follicular and the ovulation it is relatively low 29-31.  
However, skin temperature of the arms and legs is commonly measured around 6°C 
below the core, 30-31.5°C since human legs and arm tissues are used as a radiator to 
remove excess heat from the core 32,33.   Due to the core temperature changes throughout 
the menstrual cycle, skin temperature can also be altered because of the core temperature 
changes. To increase core temperature, arm and leg temperature is reduced at first to 
conserve heat 34. To lower core temperature, arm and leg temperature increases to 
dissipate heat. Since, ligament, muscle, and tendon extensibility will decrease and 
increase with decreased or increased tissue temperature, it is of no surprise that the 
menstrual cycle has dramatic effects on tissue extensibility.  Although tissue extensibility 
decreases with decreased tissue temperature, many studies have reported that anterior 
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knee laxity is greater in the ovulation phases where the core temperature is comparatively 
lower than other phases 23, 35.  However, core temperature increases after ovulation. To 
keep core temperature lower at ovulation, the shell must be dissipating more heat to keep 
the core cooler 29.  Therefore, the shell must be warmer after ovulation. Thus ligament 
elasticity change during the menstrual cycle may be a consequence of estrogen 
fluctuations alone during the menstrual cycle.  However, since sex hormones do not 
change in OCP users, their core temperature may change little during the menstrual cycle.  
In addition, Rogers and Baker have shown that OCP users have higher core temperature 
compared to non-OCP users due to exogenous forms of progesterone in OCP’s 36.   Thus, 
the effect of estrogen on ACL elasticity and muscle and tendon flexibility is probably a 
complex interaction between hormones and tissue temperature.   
 Many previous researchers examined biomechanical variables related to knee 
mechanical properties throughout the menstrual cycle 24, 37, 38.  The effect of the menstrual 
cycle on knee flexibility measured by force to flex the knee (FFK) and knee flexion-
extension hysteresis (KFEH) has not been investigated.   Restricted knee extension 
affects normal leg movement and this could lead to more non-contact ACL injuries 39. 
The quadriceps muscle is one of the knee extensor muscles, which is crucial to stabilize 
and create range of motion of the knee 40.   KFEH is the difference between the FFK and 
force to extend the knee (FEK).  Elastic energy is stored during loading the knee (flexion) 
and is released during unloading (extension); thus, flexing the knee requires greater force 
than extending the knee.  It represents stored elastic energy in the muscles and tendons, 
and lower elastic hysteresis values indicate more elasticity of muscle and tendon 41.  
5 
Therefore, we will interpret quadriceps muscle and tendon flexibility by measuring FFK 
and KFEH.  
 In the present study, two series of experiments were conducted to examine the 
relationship ACL elasticity, FFK, and KFEH during the menstrual cycle.  In series 1 
(Chapter 2), we examined the relationship between estradiol serum concentration and 
ACL elasticity, FFK, and KFEH and how this relates to tissue temperature in young 
healthy women with a regular menstrual cycle.  In series 2 (Chapter 3), we investigated 
the differences in ACL elasticity, FFK and KFEH between OCP users and non-OCP 
users and its relationship to tissue temperature during the menstrual cycle.  
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Abstract 
 
Background – A high occurrence of knee injuries have been observed in women 
during the menstrual cycle (MC).  As a result, numerous studies have been conducted 
regarding knee ligament elasticity during the MC. Some researchers believe that since 
estrogen receptor β exists in ligaments and tendons in the knee, estrogen may modulate 
towards a state of laxity. However, increased tissue temperature also observed during the 
MC can predispose ligament and tendon laxness. Therefore, the purpose of this study was 
to assess in women the relationship between Estradiol (E2) serum concentrations and 
tissue temperature during the MC and their combined effect on knee laxity. 
          Material and Methods– Ten non-athletic young healthy females, 18 to 30 years of 
age participated in the study.   E2 serum concentrations, anterior cruciate ligament (ACL) 
elasticity, and force to flex the knee (FFK), knee flexion-extension hysteresis (KFEH) 
were assessed both at ambient temperature (22 °C) and after 38 °C warming.  Testing 
was performed multiple times during the participant’s MC, for one full MC.  
            Results: ACL elasticity was significantly higher (P<0.01) and FFK and KFEH 
were significantly lower (p<0.05) during ovulation when E2 levels were highest.  ACL 
elasticity was still higher during ovulation after warming to 38 °C. But, the effects of MC 
on FFK and KFEH were reduced by tissue warming.  
            Conclusions: ACL elasticity, FFK, and KFEH was affected not only by E2 but 
also tissue temperature. However, E2 had more impact on ACL elasticity while tissue 
temperature had more impact on FFK and KFEH at 38 °C warming. 
 
Key words: menstrual cycle, ACL elasticity, muscle and tendon flexibility, temperature  
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Introduction 
In the adult population, numbers of knee injuries arise every year during sports 
activities and exercise 1. The most common injuries are ligament sprains, muscle strains, 
and contusions 2.  In the annually recorded 150,000 injuries affecting the knee, the 
Anterior Cruciate Ligament (ACL) injuries are the most frequently occurring injury.   
According to the Sports Medicine Media Guide for 2011, the cost of ACL injuries 
has been estimated at half a billion dollar annually. Additionally, people who have a 
history of ACL injury are at a higher risk of potential arthritis later in their life and will 
cost an additional millions of dollars 3. Previous studies have indicated that women have 
a 2 to 8 times higher risk factor of knee injuries than men, specifically, involving the 
ACL 4-8.  There has been ongoing debate on why women are more susceptible.   
The differences are commonly assumed to be difference by anatomical, 
neuromuscular, behavior patterns, and hormonal influences that make women more 
susceptible to ACL injuries 8, 9.  Recently investigators have examined the association 
between female reproductive hormones and structure material and mechanical properties 
of the ACL. There has been a common theory of the presence of 17-beta estradiol 
receptor in ACL for decades. The constant changes in the levels of estrogen during the 
menstrual cycle have been investigated to see if sex hormones are related to ligament 
laxity 10-13.  Human tendon, muscle, and ligament are composed of collagen fibers closely 
packed together.  Due to the decrease of collagen formation and fibroblast proliferation 
with an increased estrogen serum concentration, the decreased collagen synthesis causes 
ligament looseness, weak muscle strength and tendon elasticity all of which makes the 
ACL more susceptible to injuries 10, 11, 14.  Estradiol is one of the estrogens in women and 
9 
is the most commonly measured estrogen in young non-pregnant females 15. Since most 
ACL injuries occur in young healthy women, most investigators have used estradiol as 
the major estrogen biomarker. 
However, there has been controversy on the result of ACL laxity changes across 
the menstrual cycle.  A systemic review on the effects of the menstrual cycle on anterior 
knee laxity by Zazulak and colleague showed that only three of the nine studies reported 
a significant difference on ACL laxity during the menstrual cycle 6.  Although this study 
found limited evidence of the correlation between ACL laxity and sex hormones, Zazulak 
and colleague claimed that cycle phases might have an effect on anterior knee laxity. 
These researchers suggested that future investigators should consider the limitation in 
present methodologies that they had discovered 6.  They also point out confounding 
variables that might affect anterior knee elasticity during the menstrual cycle.  
 Temperature is one of the factors that affect elasticity in muscles, such that, an 
increase in tissue temperature by doing a warm-up exercise will increase muscle and 
tendon extensibility 16, 17.  Normal core temperature is maintained between 36-37.5°C 18, 19. 
The core temperature shows a fluctuation across the menstrual cycle; it is at a peak 
during the middle luteal phases while in the early follicular and the ovulation it is 
relatively low 20-22.  Skin temperature of the arms and legs is commonly measured around 
6°C below the core, 30-31.5°C since human legs and arms tissues are used as a radiator 
to remove excess heat from the core 23, 24.   Due to the core temperature changes 
throughout the menstrual cycle, skin temperature can also be altered because of the core 
temperature changes. To increase core temperature, arm and leg temperature is reduced at 
first to conserve heat. To lower core temperature, arm and leg temperature increases to 
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dissipate heat 25. Since, ligament, muscle, and tendon extensibility will decrease and 
increase with decreased or increased tissue temperature, it is of no surprise that the 
menstrual cycle has dramatic effects on tissue extensibility. Although tissue extensibility 
decreases with decreased tissue temperature, many studies have reported that anterior 
knee laxity is greater in the ovulation phases where the core temperature is comparatively 
lower than other phases 26, 27.  However, core temperature increases after ovulation. To 
keep core temperature lower at ovulation, the shell must be dissipating more heat to keep 
the core cooler 21.  Therefore, shell must be warmer after ovulation. These findings may 
explain that anterior knee laxity changes are a consequence of estrogen fluctuations alone 
during the menstrual cycle.  The reported change may be temperature related to and not a 
direct effect of estradiol.  Thus, the aim of the present study is to examine the relationship 
between estradiol serum concentration and ACL elasticity, knee flexibility and how this 
relates to tissue temperature in young healthy women with a regular menstrual cycle. 
 
Materials and Methods 
Participants 
Ten non-athletic young healthy females with a regular menstrual cycle 
participated in this study.  They were recruited by word of mouth and selected by their 
self-reported menstrual cycle. Participants were 18 to 30 years of age with a body mass 
index (BMI) between 15 and 30 who had a regular menstrual cycle for at least one year 
(Table 1). Participants had no history of pregnancy, neuropathy, myopathy or knee injury, 
and were not taking any medication that could alter sex hormones. The study was 
approved by Institutional Review Board of Loma Linda University and all participants 
signed an informed consent.  
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Table1. Mean (SD) of General characteristic in women with a regular menstrual cycle 
(N=10) 
  Age (years) Height (cm) Weight (kg) BMI Cycle length (d) 
Mean (SD) 24.7 (2.0) 164.6 (3.4) 57.1 (5.0) 21.0 (1.3) 29.5 (3.2) 
Abbreviations: SD, standard deviation 
 
 
Methods 
Trained researchers measured all outcome variables throughout the experiments. 
The outcome variables assessed were ACL elasticity, force to flex the knee (FFK), knee 
flexion-extension hysteresis (KFEH), leg skin temperature, and estradiol serum 
concentration.  
 
Estradiol Serum Concentration 
Two certified phlebotomists drew 4cc of venous blood samples from each 
participant’s antecubital area with 23-guage needles to determine estradiol serum 
concentration. The serum was separated from plasma by centrifuging the blood. The 
centrifuge was set at 3000 rpm for 10 minutes (Beckman Coulter Inc., Brea, CA). The 
serum was kept at a temperature of -80 °C. After all samples of serum were collected, 
Estradiol serum concentration was assessed using the TOHSO Estradiol ST AIA assay 
(Fisher Healthcare Inc. Houston, TX). 
 
Leg Skin Temperature 
Leg skin temperature was measured using the forward-looking infrared 660 IR 
Camera (FLIR systems, Danderyd, Sweden). This device was validated to accurately 
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detect the temperature of the skin 28. To acquire best images, the readings were at a 
perpendicular angle and at a distance of one meter away from the skin. Dark colored 
rooms were preferred to minimize infrared interference so that test was performed in the 
room with uniform Light Emitting Diode (LED) 29.  Baseline leg skin temperature was 
taken before ACL laxity and quadriceps elasticity measurements after stabilizing leg 
temperature in a neutral environment for 20 minutes and leg skin temperature was 
measured immediately when the heat pads at 38 °C were removed.  
 
Anterior Ligament Elasticity 
Knee elasticity of ACL was measured by a KT-2000 knee arthrometer (MED 
metric Corp, San Diego, California). This device had been validated for over twenty 
years in both clinical and research areas 30, 31.  First, the knee was placed in a 
predetermined position while the participant lays supine.  With the knee at 90 degrees, a 
strain gauge was used to measure the force necessary to generate an anterior glide of the 
proximal end of the tibia on the femoral condyles.  This generated a force curve of 
elasticity in the anterior cruciate ligaments. The process was accomplished by supporting 
both limbs with a firm, comfortable platform placed proximal to the popliteal space.  This 
helped keep the patient’s knee flexion angle constant for the duration of the test.  Along 
with this device, a foot support accessory supplied with the arthrometer, positioned the 
feet symmetrically allowing the leg position to be optimal for the test while reducing 
external rotation of the tibia.  For the most comfortable position during the flexion angle 
test, knee flexion angle was held at 25 degrees (Figure 1).  A thigh strap, provided, 
controlled hip external rotation while offering support allows patients to be most relaxed. 
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Force used for the experiment was applied at 30 lbs. (133N) of force. The output of ACL 
elasticity was displaced on an X-Y plotter. A vernier caliper was used to interpret anterior 
tibal displacement (ATD) graph.  A single trained investigator measured ACL laxity 
measures throughout the study to minimize potential inter investigation variation.  
 
 
Figure1. Experimental setup for measuring ACL elasticity, the subject was positioned 
supine with their knee flexed to 25 degrees.  
 
 
Muscle and Tendon Flexibility 
Muscle and tendon flexibility was measured by a continuous passive motion 
device (CPM). Participants were asked to sit on the edge of the table while the leg hung 
freely. The knee was moved through 35 degrees of motion from 90 to 125 of knee flexion 
by CPM. The FFK and KFEH measured the flexibility of muscle and tendon. An 
electronic goniometer was placed on lateral side of the thigh leg to measure the degrees 
14 
of knee flexion while passively moving the knee. The goniometer used a ruby bearing 
360 degree 5000 ohm potentiometer (Figure2). The output was digitized on Bio Pac MP 
150 data collection system (Bio Pac System, Goleta, CA). The force needed to move the 
leg at 115 degrees of knee flexion was used to assess difference in FFK and KFEH.   
 
 
Figure2. Experimental setup for measuring FFK and FEK of the knee, the subject was 
positioned sit with their hip and knee flexed to 90 degrees.  
 
 
The elastic hysteresis curve, which is the difference between the FFK and force to 
extend the knee (FEK), was also measured by CPM (Figure 3).  Elastic energy stored 
during the loading the knee (flexion) is greater than that of unloading (extension); thus, 
15 
flexing the knee requires greater force than extending the knee 32.  A lower elastic 
hysteresis value indicates more elasticity of the muscle and tendon.   
 
 
 
Figure3. The elastic hysteresis curve, which is the difference between the FFK and FEK, 
as measured by CPM.  
 
 
Control of Quadriceps and Knee Temperature 
Quadriceps and knee temperature were controlled with Berg’s polar care therapy 
heat exchange unit (Berg Inc. East Carlsbad, CA). Water temperature of the bath was 
maintained 40°C by a water bath. A heating water bath circulator (Fisher scientific Inc. 
Pittsburgh, PA) was attached to the water bath to control the water bath temperature. 
Since water temperature dropped about 2 °C from the water bath to the therapy pad. 
Water temperature was kept at 40°C. This way each participant was given 38°C heat on 
their knee and quadriceps. 
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Procedures 
Participants signed an informed consent form prior to their involvement. All tests 
were performed seven times depending on each participant’s menstrual phases 
throughout one full menstrual cycle. Since the estradiol serum concentration in blood and 
body temperature fluctuates during the day, the tests were performed at the same time 
each experiment day.  
On the first day, physical characteristics were measured including height, weight, 
BMI, and self-reporting menstrual cycle.  Upon arriving to the examination area, 
participants rested comfortably in a regulated ambient temperature of 22 °C for 20 
minutes to stabilize their body temperature in a neutral environment.  First, 4cc of blood 
samples were taken to analyze estradiol serum concentration before measuring leg skin 
temperature.  Next, ACL elasticity, FFK, and KFEH were measured. After this, two 38°C 
heat pads were placed on each participant’s quadriceps and knee for 20 minutes to control 
their leg temperature, skin temperatures, ACL elasticity, FFK, and KFEH measurements 
were repeated. 
 
Data Analysis 
Kolmogrov_Smirnov test was conducted to examine the distribution of estradiol 
serum concentration, leg skin temperature, ACL elasticity, FFK, and KFEH. One-way 
repeated measures analysis of variance (ANOVA) was used to examine mean estradiol 
serum concentration, leg skin temperature, ACL elasticity, and the FFK at seven different 
phases in the menstrual cycle at ambient temperature. LSD pairwise comparisons test for 
17 
multiple comparisons was used to compare means of variables between any two different 
testing phases.  A mixed factorial ANOVA was conducted to compare cycle phases with 
respect to the effect of estradiol on ACL elasticity, FFK, and KFEH at ambient 
temperature and 38°C warming. The level of significance was set at p < 0.05. 
 
Results 
  The distribution of estradiol serum concentration, leg skin temperature, ACL 
elasticity, FFK, and KFEH was approximately normal (p>0.05). Mean and Standard 
Deviation (SD) of number of days, estradiol serum concentration, and leg skin 
temperature in seven different phases of the menstrual cycle is listed in Table 2.  The 
Participant’s phases were determined by their self-report and estradiol serum 
concentration. Mean (SD) of the Anterior tibial displacement (ATD), FFK and KFEH at 
ambient temperature and 38°C warming in seven different testing phases during the 
menstrual cycle are shown in Table 3.   
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Table2. Summary of Outcome Variables in 7 Different Test Phases during the Menstrual Cycle (N=10) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: SD, Standard deviation; M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation; EL, 
Early Luteal; ML, Middle Luteal; LL, Late Luteal 
^ Significant changes from menstruation  
# Significant changes from early follicular phase 
* Significant changes from ovulation phase 
 
  
Outcome Measure M EF LF O EL ML LL p- value 
 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
 
Number of days 
 
2.2 
(0.8) 
6.3 
(1.38) 
10.2 
(1.28) 
14.2 
(2.2) 
17.8 
(2.7) 
23.4 
(2.4) 
28.1 
(3.2) <0.001 
Estradiol, pg/ml 
 
51.4 
(9.0) 
68.3 
(14.3) 
82.5 
(17.6) 
175.8 
(45.9) 
103.9 
(26.3) 
130.3 
(38.8) 
68.7 
(17.0) <0 001 
Knee skin temperature, °C 
31.8 
(0.7) 
31.4 
(0.4) 
31.7 
(1.0) 
31.5 
(0.8) 
31.9#* 
(0.8) 
31.8# 
(0.5) 
31.8# 
(0.6) 0.39 
Quadriceps skin temperature, °C 
31.8 
(0.9) 
31.5 
(0.5) 
31.8 
(1.1) 
31.6 
(0.7) 
32.1#* 
(1.0) 
31.9# 
(0.7) 
31.9 
(0.98) 0.29 
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Table3. Summary of Biomechanical Variables in 7 Different Test Phases during the Menstrual Cycle at Ambient 
temperature and 38°C warming (N=10) 
 ATD, mm FFK, N FKEH, N 
Phase Pre Heat 
Mean(SD) 
Post Heat 
Mean(SD) 
p-value a 
Pre Heat 
Mean(SD) 
Post Heat 
Mean(SD) 
p-value a 
Pre Heat 
Mean(SD) 
Post Heat 
Mean(SD) 
p-value a 
M 5.1(1.5)* 5.5(1.6)*^ <0.01 126.0(35.4)*^ 113.2(23.8) 0.04 34.4(9.1)*^ 28.4(8.0) <0.01 
EF  5.4(1.5)*^ 5.5(1.8)* 0.43 123.9(34.2) 112.0(31.3) 0.05 30.0(8.7)* 26.9 (10.4) 0.07 
LF 5.4(1.7)* 5.6(1.7) 0.24 116.6(38.0) 110.9(34.6) 0.01 28.9 (7.4)^ 25.0 (9.2) 0.03 
O 5.9(1.7)^ 6.0(1.8) 0.41 111.2(24.6) 109.0(25.9) 0.36 27.0(6.0) 24.2(8.7) 0.44 
EL 5.4(1.6)* 5.8(1.7) 0.02 122.4(31.9) 111.5(31.2) <0.01 30.6 (7.2)* 25.5(7.8)      0.05 
ML 5.7(1.7)^ 5.8(1.6) 0.66 115.2(18.4) 108.9(30.2) 0.2 30.0(7.0)* 25.6(5.3) 0.02 
LL 5.2(1.2)* 5.4(1.0) 0.26 122.1(27.7) 112.0(27.4) 0.02 30.9 (9.1) 24.9(6.8) <0.01 
p-value b 0.03 0.35  0.2 0.82  0.06 0.71  
Abbreviations: SD, Standard deviation; M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation; EL Early 
Luteal; ML, Middle Luteal; LL, Late Luteal 
^ Significant changes from menstruation  
# Significant changes from early follicular phase 
* Significant changes from ovulation phase 
a p- values for the null hypothesis that there is a no difference between pre and post heat 
b p- values for the null hypothesis that there is a no difference across 7 phases of the menstrual cycle 
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Estradiol Serum Concentration 
As shown in Figure 4, estradiol concentrations significantly changed throughout 
the menstrual cycle (p<0.001).  The lowest estradiol concentration was found during 
menstruation (51.4±9.0 pg/ml) and the peak of estradiol concentration was found during 
ovulation (175.8±45.9 pg/ml, Table 2).  
 
 
Figure4. Mean ± SD of estradiol serum concentration measured in 7 different phases 
during the menstrual cycle.  
+Abbreviations: M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation; 
EL, Early Luteal; ML, Middle Luteal; LL, Late Luteal 
 
 
Leg Skin Temperature 
Results indicated that there were no significant differences in knee and quadriceps 
skin temperatures during the menstrual cycle at ambient temperature (p>0.05, Table 2). 
However, there was a significant difference in knee skin temperature between the early 
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follicular and the early luteal phase (31.4 ± 0.4 °C vs. 31.9±0.8 °C, p=0.01).  The 
quadriceps skin temperature was also significantly higher in the early luteal phase than 
early follicular phases (32.3±1.0 °C vs.31.5 ±0.5 °C, p=0.04). Leg skin temperature 
significantly increased and held at 38 °C warming when two heat pads were applied on 
the knee and quadriceps. 
 
Anterior Knee Ligament Elasticity 
Anterior knee ligament elasticity was a measure of ATD. The greatest ATD 
during ovulation occurred both at ambient temperature and after 38 °C warming (Figure 
5). ATD during ovulation was significantly higher than any other phase at ambient 
temperature (p=0.03). There was also a significant difference in ATD between 
menstruation and ovulation as well as between early follicular and menstruation at 38 °C 
warming (p<0.05, Table 3). The greatest ATD was observed when estradiol peaks while 
the opposite occurred with lower estradiol concentration across the seven phases during 
the menstrual cycle. There were significant differences in ADT between ambient 
temperature and 38 °C warming during menstruation and early luteal phases (Table 3).  
 22 
 
Figure5. Mean ± SD of the ATD measured in 7 different phases during the menstrual 
cycle at ambient temperature and 38°C warming. 
+Abbreviations: M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation; 
EL, Early Luteal; ML, Middle Luteal; LL, Late Luteal 
 
 
Measurement of Muscle and Tendon Flexibility 
Force to Flex the Knee (FFK) 
The FFK decreased 15% from menstruation to ovulation at ambient temperature 
(p=0.4, Table 3). However, no significant changes in FFK across the menstrual phases at 
38 °C warming were detected (p>0.05, Table 3). Also, a significant difference was found 
in the FFK in between the ambient temperature and 38°C warming all the phases except 
the ovulation and the middle luteal phase in which estradiol concentrations were 
relatively higher than other phases (Table 3, Figure 6).  
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Figure6. Mean ± SD of the FFK measured in 7 different phases during the menstrual 
cycle at ambient temperature and 38°C warming. 
+Abbreviations: M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation; 
EL, Early Luteal; ML, Middle Luteal; LL, Late Luteal 
 
 
Knee Flexion-Extension Hysteresis (KFEH) 
 Figure 4 shows the KFEH curve across the seven phases. As shown in Figure 7, 
there were significant differences of KFEH over the phases at ambient temperature. The 
KFEH increased 25% from ovulation to menstruation (26.0±6.0 N vs. 34.5±9.1 N, p<0. 
01), 15% from ovulation to the early luteal (26.0±6.0 N vs.30.63±7.23 N, p=0. 04), and 
13% from ovulation to the middle luteal phases (26.0±6.0 N vs.29.97±6.98 N, p=0. 03). 
However, there were no significant changes in the KFEH over the phases at 38 °C 
warming (p>0.05). The KFEH was significantly higher at 38 °C warming as compared to 
that at ambient temperature in all phases except the ovulation (P<0. 05, Figure 6).  
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Figure7. Mean ± SD of the KFEH measured across the 7 different phases during the 
menstrual cycle at ambient temperature and 38°C warming 
+Abbreviations: M, Menstruation; EF, Early Follicular; LF, Late Follicular; O, Ovulation; 
EL, Early Luteal; ML, Middle Luteal; LL, Late Luteal 
 
 
Discussion 
ACL injury is more common in women compared to men who participate in the 
same activities.  Numerous studies have been conducted on changes of knee ligament 
elasticity during the menstrual cycle to examine the correlation between sex hormones, 
which fluctuate over the menstrual cycle, and ACL laxity 33, 34.  In spite of that, 
researchers are still debating on the results of these studies because the study methods 
and procedures were vastly different. Increased tissue temperature could be one factor 
that causes ligament and tendon laxness 16.  In this investigation, ACL elasticity, FFK, 
and KFEH were measured during seven different phases of the menstrual cycle at 
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ambient temperature and after warming the leg to 38 °C in young healthy women with a 
regular menstrual cycle. 
  The most important finding of the present study was a significantly greater ACL 
elasticity, less FFK, and KFEH during ovulation where estradiol concentration peaks 
compared to the mensturation where estradiol level is lowest during the menstrual cycle. 
The relationship between sex hormones, especailly, estrogen and  knee ligament elasticity 
as well as  between estrogen and musculotendinous stifnesss in young women with  a 
regular mentrual cycle, has been demonstrated 13, 35-37.   However,  this study is the first to 
examine the relationship between estradiol serum concentration and knee elasticity and 
its relationship to tissue temperature in young healthy women with a regular menstrual 
cycle. Greater ACL elasticity was found to occur during ovulation. There are two factors 
that may cause this: 1) estrogen and 2) tissue temperature. Heat is generally used to 
increase the elasicity and flexibility of soft tissues 38.  Ligaments must have more 
elasticity with relatively higher temperature since these are elastic stuctures 43.  In this 
investigation, skin temperature was comparably lower during ovulation than menstruation 
and the early follicular phase.  But the only  improtant temperature is the temperature of  
deep tissue.  There are very few papers on deep shell tissue temperature in deep tissues 
during the menstrual cycle 22.  These investigations found that muscle temperature was 
significantly elevated during ovulation and the well documented increase in core 
temperature. This is because heat has to be conserved by skin to get increased body 
temperature.   Heat goes through the muscle and leaves the skin by radiation, convection, 
conduction, and evaporation. Skin needs to be cooler than the core temperature to aid in 
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heat loss or conserve heat 25.  Therefore, to keep the body cool at ovulation, the shell 
needs to remove more heat; hence muscle temperature increases at ovulation.  
When the knee was heated to 38 °C, there was still difference in ACL elasticity at 
ovulation when compared to other phases of the menstrual cycle. Therefore, while the 
temperature change in deep tissues causes increased laxness, so must estradiol. Both are 
synergistic at ovulation in increasing ACL elasticity. However, previous studies 
examining ACL elasticity did not control tissue temperature. Therefore, if it was a cool 
day, the cool temperature of the shell would increase ACL stiffness and its effect would 
be cancelled.  Clothing and ambient temperature become important to consider in studies 
and may be the reason the results were so varied in different studies. No previous study 
has even had subjects acclimatized to room temperature before measuring measurements.  
This study also measured the FFK and KFEH in knee felxion and extension. 
These measures examined muscle and tendon flexibility. Human muscles and tendons are 
soft tissues composed of collagen fibers, which may be also affected by estradiol 
concentration and temperature as explained above. Results of this sutdy showed a 
significantly lower FFK and KFEH at ovulation compared to menstruation. This finding 
indicates that  less muscle and tendon stiffness are shown in the ovulation than 
menstruation statge. In addition, this result may infer that less muscle flexibility occurs 
with increased estradiol concentration and lower skin temperature which may lead to 
higher muscle tissue temperautre in young healthy women.  However, for the knee, the 
probable effect of estradiol is different. There was more energy storage at ovulation 
showing increased laxity. When the leg was warmed to the core temperature, this effect 
disappeared. This result implies that the flexibility is more affected by temperature than 
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estrogen; although estrogen is responsible for the temperature fluctuation.  Thus, using 
heat would be beneficial on increasing knee flexibility; the optimal time would be in the 
menstruation and early follicular phase, where the less flexibility occurs. 
Knee joint stiffness is a major risk factor for non-contact ACL injuries 39. It is so 
common for athletes to do warm-up stretching or use heat packs to decrease stiffness 
before exercise for injury prevention 40.  Women have greater knee stiffness due to 
estradiol and temperature effects during menstruation.  However, this investigation did 
not examine how knee stiffness is related to injuries.  Laxity may cause injuries or may 
not. Myklebust and colleague and Slatuterbeck and colleague reported that there are more 
ACL injuries during menstruation where less ACL elasticity was found 41, 42.  On the other 
hand, Wojtys and colleague claimed that more ACL injuries occur during ovulation 
where greater ACL elasticity was found 43.  However, these studies did not control 
environment or tissue temperature.  Temperature may be another factor that affects ACL 
injuries but previous studies did not examine ACL elasticity under the same condition 
such as controlling the effects of clothing or environment temperature.  If women play 
sports during ovulation in a hot environment, both temperature and estrogen causes 
excessive knee laxity which can leads to more knee injuries. However, if women play 
sports during menstruation in cold environments, both temperature and estrogen cause 
excessive knee stiffness that can lead to more knee injuries. Thus, in further investigation, 
both estrogen and temperature should be considered as key risk factors that can cause 
ACL injuries during menstrual cycle.  
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Conclusions 
ACL elasticity, FFK, and KFEH were affected not only by estradiol serum 
concentration but tissue temperature during the menstrual cycle. However, estradiol 
serum concentration had more impact on ACL laxity while tissue temperature had 
more impact on FFK and KFEH at 38 °C warming. 
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Abstract 
 Introduction: Eighty two percent of sexually active women aged 15-44 have used 
oral contraceptive pills (OCP) in the United States.  Hormone changes during the 
menstrual cycle (MC) are believed to have an impact on anterior cruciate ligament (ACL) 
laxity due to estrogen.  OCP may have a potention impact on tendon and ligament 
synthesis, structure, and biomechanical properties.  Temperature has also been known to 
have an effect of on tissue elasticitiy.  Therfore, the purpose of this study was to 
investigate the differences in ACL elasticity, force to flex the knee (FFK), and knee 
flexion-extension hysteresis (KFEH) between OCP users and non-OCP users and its 
relationship to tissue temperature.   Methods: Nineteen non-athletic young healthy 
females were divided into two groups; OCP users and non-OCP users.  Blood for estradiol 
serum concentration (E2) was taken before beginning the tests.  ACL elasticity, FFK, and 
KFEH were assessed both at ambient temperature (22 °C) and after 38 °C warming of the 
leg to stabilize the tissue temperature.  Assessments were performed four times during the 
MC.  Results: Throughout the MC, ACL elasticity, FFK, and KFEH fluctuated in non-
OCP users but not in OCP users. At ambient temperature, ACL elasticity was significantly 
lower and FFK and KFEH were significantly higher in OCP users than non-OCP users 
(p<0.05). But, no significant differences in FFK and FFEH between the two groups were 
found after warming to 38 °C.  
Conclusions: The effect of MC on ACL is both hormonal and temperature related while 
the knee is temperature related. 
Key words: Oral contraceptive pill, Knee elasticity, Muscle and tendon flexibility, and 
Tissue temperature 
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Introduction 
 Women have a greater incidence of Anterior Cruciate Ligament (ACL) injury 
than men 1-4.  This gender differnce is commoly assumed to be due to anatomical, 
neuromuscular, movement patterns, in women as well as hormonal influences 4, 5.  
Regarding hormonal factors, numerous studies have found a correlation between 
reproductive hormones and ACL injury risk 1-4.  The role of estrogen in possibly causing 
ACL injuries has recently been studied at the celluar level and the presence of 17- beta 
estradiiol receptors in human ACL and muscle has been investigated 6-9.  Previous studies 
have examined the changes in the levels of estrogen in blood as related to ACL laxity 
during the menstrual cycle and a correlation between ACL laxity and estrogen was 
detected 6-9.  
 The number of women using OCP has constantly increased.  Eighty two percent 
of sexually experienced women aged 15-44 have used the oral contraceptive pill (OCP) 
in the United States and 14% of women have used OCP for non-contraceptive purposes 
such as cycle regulation, treatment of dysmenorrhea and amenorrhea 10.  OCP consists of 
combined estrogen and progesterone as synthetic steroids and it plays a role in 
suppressing pituitary FSH and LH production and preventing ovulation from occurring 10, 
11. This exogenous source of synthetic forms of the hormone prevents ovulation by 
maintaining more consistent hormone levels 12. The 17- beta estradiol receptors on human 
connective tissue is well known and therefore, the OCP may have an impact on tendon 
and ligament synthesis, structure, and biomechanical properties.  Also, Martineau and 
colleagues have shown that OCP usesrs have less ACL laxity than non-OCP users 13.   
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 It is not surprising that many people do a warm-up exercise before sports 
activities to increase muscle and tendon extensibility to prevent injuries 14.  Temperature 
is another factor that influences tendon and ligament of collagen synthesis.  In healthy 
young adults, core temperature changes approximately 0.5°C throughout the day. In 
women with a regular menstrual cycle, their core temperature fluctuates not only 
throughout the day but also during the menstrual cycle 15.   It peaks during the luteal 
phase while in the follicular and at ovulation it is relatively low 15-17.   The elevated 
thermoregulatory set point during the luteal phase is the most accepted explanation for 
the observed change in core temperature 18, 19.  Since, soft tissue extensibility changes with 
different levels of tissue temperature; the menstrual cycle has dramatic effects on tissue 
extensibility.  However, because hormones do not change in OCP users, their core 
temperature may change little during the menstrual cycle.  In addition, Rogers and Baker 
have shown that OCP users have higher core temperature compared to non-OCP users 
due to exogenous forms of progesterone in OCP’s 20.  
 Thus, the effect of estrogen on ACL elasticity and muscle and tendon flexibility is 
probably a complex interaction between the hormone and tissue temperature.  Therefore, 
the purpose of this study was to investigate the differences in ACL elasticity, force to flex 
the knee (FFK) and knee flexion-extension hysteresis (KFEH) between OCP users and 
non-OCP users and its relationship to tissue temperature during the menstrual cycle.  
 
Materials and Methods 
Subjects 
Twenty non-athletic young healthy females volunteered to participate in this 
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study. Subjects were divided into two groups: subjects with a regular menstrual cycle and 
those who are taking OCP according to their self-reporting. Subjects were 18 to 30 years 
of age with a Body Mass Index (BMI) between 15 and 30 who had a regular menstrual 
cycle or currently using low-dose OCP (<50µg-ethinyl estradiol) for at least six months. 
Subjects had no history of pregnancy, neuropathy, myopathy or knee injury, and were not 
taking any medication would affect sex hormones other than OCPs. All procedures and 
protocols were approved by Institutional Review Board of Loma Linda University and all 
subjects signed an informed consent. 
 
Procedures 
Subjects performed a total of four different tests throughout one full menstrual 
cycle. Subjects were asked to report the days of their cycle at the beginning of the study.  
OCP users were screened by questionnaire, which included questions regarding brand 
name, type, and the length of taking OCP.   At the beginning of the study, subjects signed 
an informed consent before they participated in the study. Since the estradiol serum 
concentration in blood and body temperature fluctuates during the day, the various tests 
were performed at the same time each day.  
 On the first day, before beginning the experiment, height, weight, BMI, and self-
reported menstrual cycle were measured.  Upon arriving at the laboratory, subjects rested 
comfortably in a regulated temperature room at 22 °C for 20 minutes to stabilize their 
body temperature in a neutral environment.  Blood samples (4cc) were taken to analyze 
estradiol serum concentration before measuring leg skin temperature.  Next, ACL 
elasticity, FFK, and KFEH were measured. After this, two 38°C heat pads were placed on 
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the subject’s quadriceps and knee for 20 minutes to stabilize their leg temperature. Skin 
temperature, ACL elasticity, FFK, and KFEH measurements were repeated.  
 
Measurements 
A trained researcher performed all measurements.  The outcome variables assessed 
were ACL elasticity, force to flex the knee (FFK), knee flexion-extension hysteresis 
(KFEH), leg skin temperature, and estradiol serum concentration.  
 
Estradiol (E2) Serum Concentration 
 Estradiol serum concentration was analyzed using the TOHSO E2 ST AIA assay 
(Fisher Healthcare, Inc., Houston, TX, USA). Four cc of blood was obtained from an 
antercubutal vein with a 23-guage needle and centrifuged for separating serum from 
plasma. The centrifuge rotated at 3000 rpm for 10 minutes (Beckman Coulter Inc., Brea, 
CA). Once serum was separated, it was stored at -80°C until all samples of serum were 
collected for the hormone analysis.  
 
Leg Skin Temperature 
 Leg skin temperature was measured using the forward-looking infrared 660 IR 
Camera (FLIR systems, Danderyd, Sweden). This device has been validated to deliver 
accurate temperature measurements 21. To acquire best images, the readings were at a 
perpendicular angle and at a distance of 1 meter away from the skin. Measurements were 
performed in the room illuminated with light emitting diode (LED) lights to minimize 
any infrared interference 21. Baseline leg skin temperature was taken after stabilizing leg 
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temperature at a neutral environment for 20 minutes and after applying 38 °C heat 
immediately when the heat pads were removed.  
 
Anterior Knee Ligament Elasticity 
 KT-2000 knee arthrometer (MED metric Corp, San Diego, California) was used 
to measure knee laxity of the anterior cruciate ligament. The measurement of the anterior 
knee ligament laxness was performed by one experienced examiner for consistency. 
Subjects were asked to lay supine in a predetermined position. A strain gauge was used to 
measure the force necessary to generate an anterior glide of the proximal end of the tibia 
on the femoral condyles.  This generated a force curve of elasticity in the anterior cruciate 
ligaments. The process was accomplished by supporting both limbs with a firm, 
comfortable platform placed proximal to the popliteal space.  This helped keep the 
subject’s knee flexion angle constant for the duration of the test.  Along with this device, 
a foot support accessory supplied with the arthrometer, positioned the feet symmetrically 
allowing the leg position to be optimal for the test while reducing external rotation.  For 
the most comfortable position during the flexion angle test, knee flexion angle was held 
at 25 degrees (Figure 8).  A thigh strap controlled hip external rotation while offering 
support in order to help relax the subject.  Force used for the experiment was applied at 
30 lbs. (133N) of force. The force displacement data was shown on an X-Y plotter. A 
venire caliper was used to measure anterior tibial displacement (ATD) graph.  
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Figure8. Experimental setup for measuring ACL elasticity, the subject was positioned 
supine with their knee flexed to 25 degrees.  
 
 
Muscle and Tendon Flexibility 
 The angle of the force measured to extend the knee was from 90 to 125 degrees.  
Elevated off the floor and in a seated position, the subject's leg hung at an initial angle of 
90 degrees.    To passively move the knee through 35 degrees of flexion and extension, 
an ankle strap was connected to a linear actuator (Figure 9).   The measurement was 
recorded at a rate of movement of 45 degrees in 7.5 seconds.    The force in flexion and 
extension was measured with a strain gage bridge amplified with a gain of 500(DAC 100, 
Bio Pac Systems, Goleta California). The output was then digitized at 2000 hertz with a 
resolution of 24 bits on an MP150 Bio Pac data acquisition system (Bio Pac Systems, 
Goleta California).  The knee goniometer, using a ruby bearing 360 degree 5000 ohm 
potentiometer, measured the angle of the knee to calculate the force needed per degree  
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Figure9.  Experimental setup for measuring FFK and FEK of the knee, the subject was 
positioned sitting with their hip and knee flexed to 90 degrees.  
 
 
 The difference between the FFK and force to extend the knee (FEK), called 
KFEH, was then calculated.   Potential elastic energy stored during the loading (flexion) 
is greater than that of unloading (extension); thus, flexing the knee required greater force 
than extending the knee 22. A lower elastic hysteresis value means more elasticity of the 
muscle and tendon (Figure 10).   
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Figure10. The elastic hysteresis curve, which is the difference between the FFK and FEK, 
as measured by CPM.  
 
 
Control of Quadriceps and Knee temperature 
 Quadriceps and knee temperature were controlled with a Berg’s polar care 
therapy heat exchange unit (Berg Inc. East Carlsbad, CA) maintained at 40°C by a water 
bath. On the water bath, a heating water bath circulator (Fisher scientific Inc. Pittsburgh, 
PA) was attached to control temperature. Since water temperature dropped about 2 °C 
throughout the unit, water temperature was kept at 40°C to give 38°C heat on subject’s 
knee and quadriceps.  
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Data Analysis 
Data was summarized using means and standard deviation (SD). An independent 
t-test was conducted to compare general characteristics between OCP users and non-OCP 
users.  One-way repeated measures analysis of variance (ANOVA) was used to examine 
changes in mean estradiol serum concentration, leg skin temperature, ACL elasticity, 
FFK, and KFEH at four different phases of the menstrual cycle. For significant findings, 
LSD pairwise comparisons test for multiple comparisons was used to compare means of 
variables between any two different phases. For all data collected over the phases within 
each test, a mixed factorial ANOVA was conducted to compare cycle phases with respect 
to the effect of estradiol concentration on ligament elasticity, FFK, and KFEH at room 
temperature and 38°C in each group. The level of significance was set at p < 0.05.  
 
Results 
  Ten subjects were enrolled in each group. However, one subject from the OCP 
group was excluded because the estradiol level was similar to that of a normal menstrual 
cycle subject.  There were no significant differences in mean age, weight (kg), height 
(cm), BMI (kg/m2), and length of cycle (p>0.05, Table 4).  The subject’s menstrual phase 
was determined by their self-reporting and estradiol serum concentrations. Mean (SD) of 
the ADT, FFK, and KFEH at ambient temperature and 38°C warming in four different 
phases during the menstrual cycle is shown in Table 6,5,7. 
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Table 4. Mean (SD) of general characteristics (N= 19) 
 Non-OCP users OCP users p –value* 
Age (years)                24.7 (2.0) 25.1(3.3) 0.74 
Height (cm)                164.6 (3.4) 165.7(5. 1) 0.59 
Weight (kg) 57.1 (5.0) 59.4(7.0) 0.35 
BMI (kg/m2) 21.0 (1.3) 21.6(4.1) 0.48 
Cycle length (d) 29.5 (3.2) 28.6(1.1) 0.38 
Abbreviation: SD, Standard deviation; OCP, Oral contraceptive pills 
* Independent t-test  
 
 
Table 5. Summary of Outcome Variables in 4 Different Test Phases during the Menstrual 
Cycle (N=19) 
 Outcome Measure M F O L P-value 
 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
 
Number of days      
Non-OCP users 2.2(0.8) 10.2(1.3) 14.2(2.2) 23.4(2.4)  <0.001 
OCP users 2.1(0.5) 9.1(0.9) 13.8(1.2) 22.9(1.6)  <0.001 
Estradiol, pg/ml      
Non-OCP users 51.4 (8.9) 82.5 (17.6) 175.8 (45.9) 130.3 (38.8)  <0.001 
OCP users 29.6 (5.3) 34.8 (11.1) 31.3 (9.7) 32.7 (9.9)   0.42 
Knee skin temperature, °C      
Non-OCP users 31.8(0.7) 31.7(1.0) 31.5(0.8) 31.8(0.5)#   0.43 
OCP users 31.8(0.3) 31.8(0.3) 31.7(0.3) 31.9(0.5)   0.74 
Quadriceps skin temperature, °C      
Non-OCP users 31.8(0.9) 31.8(1.1) 31.6(0.7) 31.9(0.7)#   0.52 
OCP users 31.9(0.7) 31.8(0.8) 32.0(1.3) 31.9(0.9)   0.88 
Abbreviations: SD, Standard deviation; M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral 
contraceptive pills 
 # Significant changes from ovulation 
 
 
 45 
Estradiol (E2) Serum Concentration 
 Mean and SD of estradiol serum concentrations in four different phases during the 
menstrual cycle is displayed in Table 5. There were significant changes in estradiol serum 
concentration found across the menstrual cycle in the OCP user group (P<0.001), but not 
in OPC group (Figure 11, Table 2).  The lowest estradiol concentration was found during 
menstruation (51.4±9.0 pg/ml) and the highest estradiol concentration was found during 
ovulation (175.8±45.9 pg/ml) in non-OCP user group (Table 5). 
 
 
Figure11. Mean ± SD of estradiol concentration measured in 4 different phases of the 
menstrual cycle in non-OCP users and OCP users. 
Abbreviations: M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral contraceptive pills 
 
 
Leg Skin Temperature 
 Both knee and quadriceps skin temperatures were significantly lower during 
ovulation compared to luteal phase in non- OCP users (31.5 ±0.8 vs. 31.8 ±0.5, p=0.04, 
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31.6±0.7 vs. 31.9±0.7, p=0.04, Table 5). However, there were no significant changes 
during the menstrual cycle in non-OCP users (p>0.05, Table 5). Also, no significant 
differences in temperature were detected between OCP users and non-OCP users in all 
phases (p>0.05). When two heat pads were applied on the knee and quadriceps skin 
temperature significantly increased and held at 38 °C warming 
 
Anterior Knee Ligament Elasticity 
 Anterior knee ligament elasticity was measured by ATD. The results of the ATD 
changes in four different phases during the menstrual cycle at ambient temperature and 
after 38°C warming in non-OCP and OCP users are shown in Figure 12.  When 
comparing ATD in four different phases of the menstrual cycle, ATD was significantly 
lower in OCP users compared to non-OCP at both temperatures (Figure 12). The greatest 
ATD was found at ovulation and the least ATD was found at menstruation in non-OCP 
users (Table 6).  At ambient temperature, the ATD decreased 10% from ovulation to 
menstruation and the ATD differences between ovulation and menstruation were not 
significant in OCP users (p>0.05, Table 6).  There were significant differences in ATD 
between OCP users and non-OCP users (p>0.05) after applying 38 °C warming,  There 
was a significant difference in ATD between ovulation and menstruation in OCP users 
(6.0 ± 1.8 mm vs. 5.6± 1.6 mm, p=0.01, Table 6, Figure 12).  
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Table 6. Mean (SD) of the ATD measured in 4 different phases of the menstrual cycle at 
ambient temperature and after 38°C warming in non-OCP users and OCP users (N=19). 
                              Anterior Tibial Displacement, mm 
      Group                      Non-OCP users                         OCP users 
       Phase 
 Pre Heat 
Mean (SD) 
 Post Heat 
Mean (SD) 
p-value a 
 Pre Heat 
Mean (SD) 
 Post Heat 
Mean (SD) 
p-
value a 
         M 5.1(1.5) 5.5(1.6) <0.01 4.4(0.8) 4.5(1.0) 0.51 
         F 5.4(1.7) 5.6(1.7) 0.24 4.3(0.9) 4.5(0.9) 0.16 
         O 5.9(1.7)*^ 6.0(1.8)* 0.41 4.4(0.9) 4.6(0.9) 0.08 
         L 5.7(1.7)* 5.8(1.6) 0.67 4.4(0.6) 4.6(0.8) 0.32 
      p-value b   <0.01     0.44    0.89    0.97  
Abbreviations: SD, Standard deviation; M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral 
contraceptive pills 
* Significant changes from menstruation  
^ Significant changes from follicular phase 
a p- values for the null hypothesis that there is a no difference between pre and post heat 
b p- values for the null hypothesis that there is a no difference across 4 phases of the menstrual cycle 
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(A) 
 
(B) 
 
Figure12. Mean ± SD of the ATD measured in 4 different phases of the menstrual cycle at 
ambient temperature and after 38 °C warming in non-OCP users and OCP users. 
Abbreviations: M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral contraceptive pills 
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Measurement of Muscle and Tendon Flexibility 
Force to Flex the Knee (FFK) 
 The FFK decreased 15% from menstruation to ovulation at ambient temperature 
in non-OCP users (p=0.04, Table 7).  However, there were no significant changes in the 
FFK across the phases at 38 °C warming (P>0.05). Also, a significant difference was 
found in the FFK between the ambient temperature and 38°C warming in all phases 
except ovulation in which estradiol concentrations were relatively higher than in other 
phases (Table 7).  Both at ambient temperature and 38 °C warming, the FFK of OCP 
users were greater than non-OCP users in all phases (Table 7, Figure 13). There was no 
significant difference in the FFK between pre and post heat in OCP users. On average, 
9.5% decrease was shown in OCP users versus 5.4% decrease in non-OCP users (Table 
7). 
 
Table 7. Mean (SD) of the FFK measured in 4 different phases of the menstrual cycle at 
ambient temperature and after 38°C warming in non-OCP users and OCP users (N=19). 
                                        Force to Flex the Knee, N 
      Group                        Non-OCP users                        OCP users 
      Phase 
  Pre Heat 
Mean (SD) 
 Post Heat 
Mean (SD) 
p-value a 
 Pre Heat 
Mean (SD) 
 Post Heat 
Mean (SD) 
p-value a 
         M 126.0(35.4) 113.2(23.8) 0.04 132.5(26.1) 118.0(25.6)    <0.01 
         F 116.6(38.0) 110.9(34.6) 0.01 128.2(28.1) 117.1(23.5)   0.04 
         O 111.2(24.6)* 109.0(25.9) 0.36 130.9(30.0) 117.6(24.5) <0.01 
         L 115.2(18.4) 108.9(30.2) 0.21 129.8(32.3) 119.2(24.9)   0.02 
     p-value b       0.24      0.89                       0.92      0.99  
Abbreviations: SD, Standard deviation; M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral 
contraceptive pills 
* Significant changes from menstruation  
a p- values for the null hypothesis that there is a no difference between pre and post heat 
b p- values for the null hypothesis that there is a no difference across 4 phases of the menstrual cycle 
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(A) 
 
(B) 
 
Figure13. Mean ± SD of the FFK measured in 4 different phases of the menstrual cycle at 
ambient temperature and after 38 °C warming in non-OCP users and OCP users. 
Abbreviations: M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral contraceptive pills 
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Knee Flexion-Extension Hysteresis (KFEH) 
 At ambient temperature, the KFEH was significantly lower in OCP users than non-
OCP users.  During ovulation, the KFEH was significantly lower in non-OCP users than 
OCP users (27.0 ± 6.0 N vs. 34.9±11.2 N, p<0.01, Table 8).  Across phases, there were no 
significant changes in the KFEH in non-OCP users (p=0.01) but not in OCP users 
(p=0.72).  The KFEH increased 24% from ovulation to menstruation at ambient 
temperature in non-OCP users.  In addition, there were no significant changes in the 
KFEH across the menstrual cycle at 38 °C warming in OCP users (p>0 .05). In both 
groups, the KFEH was significantly lower at 38 °C warming when compared to ambient 
temperature in all phases except ovulation.  After 38 °C warming The KFEH decreased 
21.1% in OCP users and 14.0% in non-OCP users (Figure 14, Table 8).  
 
Table 8. Mean (SD) of the KFEH measured in 4 different phases of the menstrual cycle at 
ambient temperature and after 38°C warming in non-OCP users and OCP users (N=19). 
                           Knee Flexion-Extension Hysteresis, N 
      Group                      Non-OCP users                        OCP users 
      Phase 
  Pre Heat 
Mean (SD) 
 Post Heat 
Mean (SD) 
  p-value a 
 Pre Heat 
Mean (SD) 
 Post Heat 
Mean (SD) 
  p-
value a 
         M 34.4(9.1) 28.4(8.0) <0.01 38.0(14.9) 29.3(8.0) 0.02 
         F 28.9 (7.4)* 25.0 (9.2) 0.03 35.3(14.0) 28.2(11.0) 0.04 
         O 27.0(6.0)* 24.2(8.7) 0.44 34.9(11.2) 28.1(11.2) 0.07 
         L 30.0(7.0)# 25.6(5.3) 0.02 36.0(11.1) 28.1(6.9) 0.02 
       p-value b      0.01       0.45      0.72      0.95  
Abbreviations: SD, Standard deviation; M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral  
contraceptive pills 
* Significant changes from menstruation  
# Significant changes from ovulation 
a p- values for the null hypothesis that there is a no difference between pre and post heat 
b p- values for the null hypothesis that there is a no difference across 4 phases of the menstrual cycle 
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(A) 
 
(B) 
 
Figure 14. Mean ± SD of the KFEH measured in 4 different phases of the menstrual cycle 
at ambient temperature and after 38 °C warming in non-OCP users and OCP users. 
  Abbreviations: M, Menstruation; F, Follicular; O, Ovulation; L, Luteal; OCP, Oral contraceptive pills 
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Discussion 
 ACL elasticity and muscle and tendon flexibility are major risk factors for knee 
injuries during sports 23, 24.  Women have fluctuating estrogen during the menstrual cycle, 
and are more susceptible to have injuries 25.  In previous studies, women had greater knee 
laxity during ovulation at a time when estrogen level peaks 26-28. The finding supports 
these results that estrogen receptors are found in connective tissue and thus, it changes its 
mechanical properties of tendons and ligaments 7, 28.  However, OCP makes women’s 
hormone level more consistent during the menstrual cycle. If it is true that female 
reproductive hormones cause connective tissue laxness, female OCP users should show 
more stable tissue extensibility.  Therefore, it is of no surprise that the few studies 
addressing the effects of OCP on knee injury prevention show little change in ligament 
elasticity during the menstrual cycle 29, 30.  Researchers, however, have reached different 
conclusions on the relationship between OCP and knee laxity 13, 30.  
 In the present investigation, ACL elasticity, FFK, and KFEH were measured 
during four different phases of the menstrual cycle with subjects exposed to ambient 
temperatures. In addition, to stabilize temperature fluctuation from the day, the 
experiments were repeated by warming the leg to 38°C in both young healthy OCP and 
non-OCP users.  We have found that non-OCP users have a greater ACL elasticity, less 
FFK, and KFEH in all phases compared to OCP users at ambient temperature.  We futher 
found that non-OCP users’ biomechanical outcome varaibales were altered throughout 
the mesntraul cycle, but not in OCP users during the menstrual cycle.  When comparing 
estradiol serum concentration between the two groups, OCP users estradiol levels were 
lower in all phases and did not alter during the menstrual cycle. These results imply that 
 54 
estradiol serum concention has an impact on human ligament, muscle, and tendon.  In 
other words, more knee stiffness was found in women on OCP.  Here estradiol was lower 
in blood. 
 Tissue temperature is one of  the factors that alters knee elasticity and heat is 
commonly used to reduce soft tissue stiffness 31.  Since basal body temperature fluctuates 
during the menstrual cycle, it is used to accurately detect if women are ovulating.  This 
change is also influenced by progesterone and estrogen during the menstrual cycle but 
not in OCP users 32, 33.  Previous research found that muscle temperature increased  on 
ovulation and it continuosly remaind elevated during the luteal phase 15, 17.  To increase 
central core temperature, the skin remove less heat to reduce body tempearture than skin 
loose more heat.  In non-OCP users, muscle and shell tissue temperatrue fluctuate during 
the menstraul cycle; thus playing an important role in knee elasticity.  
In addition, there were heat effects on muscle and tendon flexibility both in non-
OCP and OCP uesers. The FFK and FFEH significantly decreased after 38 °C warming 
of the leg in all phases in OCP users. In a similar manner, knee flexibility was 
significantly reduced after using heat in all phases of the menstrual cycle except 
ovulation, where estradiol serum concentration was relatively higher in non-OCP users.  
These results imply that muscle and tendon flexibility is more affected by temperature 
than estrogen. Interestingly, we found that FFK and FFEH decreased more after 38 °C 
warming in OCP users compared to non-OCP users during the menstrual cycle.  This 
indicated more effect of heat on FFK and KFEH in OCP users. Thus, using heat increases 
knee flexibility in OCP users and is still beneficial to non-OCP users during menstruation 
where estradiol levels are relatively low.  However, for the ACL, the effects of estradiol 
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were different.  The ADT did not significantly decrease after 38 °C warming in both 
groups of subjects. Also, it was significantly higher during ovulation than menstruation 
after heat.  
ACL elasticity , muscle and tendon flexibility is related to knee injuries 34.  
Women who are taking OCP have less knee laxity due to estradiol effects during 
menstruation. Previous studies have examined the association between ACL injuires and 
use of  oral contraceptives 29, 35.  However,  results from these studies were perhaps 
inconclusive because these studies did not examine the effect of  both knee elasticity and 
tissue temperature.  It is not easy to examine the effects of OCP on ACL injuries only 
with ACL elasticity.  Other factors should be considered such as tissue temperature.  
Thus, in further investigation, both estrogen and tissue temperature should be considered 
as key risk factors that can cause ACL injuries during menstrual cycle in both OCP and 
non- OCP users.  
In addition, interesitngly, it is common to do a warm up prior to exercise in order 
to reduceinjuries since less elasticity is relatd to tissue tears.  However, in women, the 
reverse seems to be true .  Perhaps, the structure strength (e.g. collagen cross bridges) is 
also altered by estrogen.  This may explain differences in the results of some studies on 
women versus men.  These knee injuries may be caused by changes in collagen strength 
not just elasticity.  Estrogen may not only alter ACL elasticity, but may cause a change in 
the breaking strength of the ACL.  Just as bone can fracture due to glycogen cross linking 
even when it is dense, there may be a similar relationship with collagen in ligaments 
whereby they may tear even if elastic.   This would involve a shift in the force stress 
curve for the ACL making the elastic region shorter and the plastic region larger due to 
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estrogen.  There are no studies on structural strength of the ACL in relation to estrogen, 
only elasticity.  It will be interesting to see if there are collagen structure strength changes 
during the menstrual cycle and its relationship to incidence of knee injuries in OCP users 
and non-OCP users.  
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CHAPTER FOUR 
DISCUSSION 
 
 Women have a higher risk factor for ACL injuries compared to men who 
participate in the same sports activities 3-6.  ACL elasticity and muscle and tendon 
flexibility are major risk factors for knee injuries during sports 42, 43.  Numerous studies 
have studied changes in knee ligament elasticity during the menstrual cycle to examine 
the relationship between sex hormones and ACL laxity 44, 45.  In several previous studies, 
women had greater knee laxity during ovulation at a time when estrogen level peaks 23, 35, 
46.  The finding supports these results that estrogen receptors are found in connective 
tissue and thus, estrogen changes the mechanical properties of tendons and ligaments 12, 23.  
In spite of that, researchers are still debating on the results of these studies because the 
study methods and procedures were vastly different 22.  However, female reproductive 
hormones are more consistent during the menstrual cycle in women on the OCP.  If knee 
ligament laxity was affected by hormone fluctuation, female OCP users should show 
more stable tissue extensibility.  
 Increased tissue temperature could be one factor that causes ligament and tendon 
laxity and heat is commonly used to reduce soft tissue stiffness 25, 47.  Basal body 
tmeperature fluctuates duing the menstrual cycle in women, and this change is also 
influenced by progesterone and estrogen 48, 49.   Previous research found that muscle 
temperature increased continuosly increased throughout the menstrual cycle and it 
remaind elevated during the luteal phase 29, 31.  Muscle temperature changed not just by 
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one but by four to five degree in Celcious which is fairly significant changes temperature 
in shell tissues during the menstral cycle 31.  Muscle and shell tissue temperature 
fluctuates during the menstraul cycle, thus temperature is also playing an important role 
in knee elasticity.  Therefore, in the present investigation, two series of experiments were 
conducted to examine the relationship ACL elasticity, FFK, and KFEH during the 
menstrual cycle.  In series 1 (Chapter 2), we examined the relationship between estradiol 
serum concentration and ACL elasticity, FFK, and KFEH and how this relates to tissue 
temperature in young healthy women with a regular menstrual cycle.  In series 2 (Chapter 
3), we investigated the differences in ACL elasticity, FFK and KFEH between OCP users 
and non-OCP users and its relationship to tissue temperature during the menstrual cycle.  
 The most important finding from series 1 was a significantly greater ACL 
elasticity, less FFK, and KFEH during ovulation where estradiol serum concentration 
peaks compared to the mensturation where estradiol level is lowest during the menstrual 
cycle. Greater ACL elasticity was found to occur during ovulation. There are two factors 
that may cause this: 1) estrogen and 2) tissue temperature. Ligaments must have more 
elasticity with relatively higher temperature since these are elastic stuctures 42.  In this 
investigation, skin temperature was comparably lower during ovulation than menstruation 
and the early follicular phase.  But the only improtant temperature is the temperature of  
deep tissue.  There are very few papers on deep shell tissue temperature in deep tissues 
during the menstrual cycle 31 . These investigations found that muscle temperature was 
significantly elevated during ovulation and the well documented increase in core 
temperature. This is because heat has to be conserved by skin to get increased body 
temperature.   Heat goes through the muscle and leaves the skin by radiation, convection, 
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conduction, and evaporation. Skin needs to be cooler than the core temperature to aid in 
heat loss or conserve heat 34.  Therefore, to keep the body cool at ovulation, the shell 
needs to remove more heat; hence muscle temperature increases at ovulation.  
When the knee was heated to 38 °C, there was still difference in ACL elasticity at 
ovulation when compared to other phases of the menstrual cycle. Therefore, while the 
temperature change in deep tissues causes increased laxness, so must estradiol. Both are 
synergistic at ovulation in increasing ACL elasticity. However, previous studies 
examining ACL elasticity did not control tissue temperature.  Even regarding the 
menstrual cycle, we go through large changes in shell temperature according to various 
phases of the year.  If studies were conducted on skiers, the results would have been 
different from tennis players.  Clothing and ambient temperature become important to 
consider in also since this alters arm and leg temperature.  This may be the reason the 
results were so varied in different studies.  No previous study has even had subjects 
acclimatized to room temperature before measuring measurements.  
This study also measured the FFK and KFEH in knee felxion and extension. 
These measures examined muscle and tendon flexibility. Human muscles and tendons are 
soft tissues composed of collagen fibers, which may be also affected by estradiol 
concentration and temperature as explained above. Results of this sutdy showed a 
significantly lower FFK and KFEH at ovulation compared to menstruation. This finding 
indicates that  less muscle and tendon stiffness are shown at ovulation than the 
menstruation statge. In addition, this result may infer that less muscle flexibility occurs 
with increased estradiol concentration and lower skin temperature which may lead to 
higher muscle tissue temperautre in young healthy women.  However, for the knee, the 
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probable effect of estradiol is different. There was more energy storage at ovulation 
showing increased laxity. When the leg was warmed to the core temperature, this effect 
disappeared. This result implies that the flexibility is more affected by temperature than 
estrogen; although estrogen is responsible for the temperature fluctuation.  Thus, using 
heat would be beneficial on increasing knee flexibility; the optimal time would be in the 
menstruation and early follicular phase, where the less flexibility occurs. 
 Results from the series 2 study show that non-OCP users have a greater ACL 
elasticity, less FFK, and KFEH in all phases compared to OCP users at ambient 
temperature.  We futher found that for non-OCP users’ biomechanical outcome 
varaibales were altered throughout the mesntraul cycle, but not in OCP users during the 
menstrual cycle. OCP users estradiol levels were much lower in all phases of the 
menstrual cycle and did not alter during the menstrual cycle. These results imply that 
estradiol serum concention has an impact on human ligament, muscle, and tendon.  In 
other words, more knee stiffness was found in women on OCP.  Here estradiol was lower 
in blood. 
In addition, there were heat effects on muscle and tendon flexibility both in non-
OCP and OCP uesers. The FFK and FFEH significantly decreased after 38 °C warming 
of the leg in all phases in OCP users. In a similar manner, knee flexibility was 
significantly reduced after using heat in all phases of the menstrual cycle except 
ovulation, where estradiol serum concentration was relatively higher in non-OCP users.  
These results imply that muscle and tendon flexibility is more affected by temperature 
than estrogen. Interestingly, we found that FFK and FFEH decreased more after 38 °C 
warming in OCP users compared to non-OCP users during the menstrual cycle.  This 
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indicated more effect of heat on FFK and KFEH in OCP users. Thus, using heat increases 
knee flexibility in OCP users and is still beneficial to non-OCP users during menstruation 
where estradiol levels are relatively low.  However, for the ACL, the effects of estradiol 
were different.  The ADT did not significantly decrease after 38 °C warming in both 
groups of subjects. Also, it was significantly higher during ovulation than menstruation 
after heat.  
However, as seen in this investigation, we did not examine how knee elasticity is 
related to injuries.  ACL elasticity and knee muscle and tendon flexibility may cause 
injuries or may not.  Temperature may be another factor that affects ACL injuries but 
previous studies did not examine ACL elasticity under the same condition such as 
controlling for the effects of clothing or environment temperature. Also, previous studies 
have examined the association between ACL injuires and use of  oral contraceptives 53,54.  
However,  results from these studies were perhaps inconclusive because these studies did 
not examine the effect of  both knee elasticity and tissue temperature.  It is not easy to 
examine the effects of OCP on ACL injuries only with ACL elasticity.  Other factors 
should be considered such as tissue temperature.  Thus, in further investigation, both 
estrogen and tissue temperature should be considered as key risk factors that can cause 
ACL injuries during menstrual cycle in both OCP and non- OCP users.  
In addition, interesitngly, it is common to do a warm up prior to exercise to 
reduce injuries since less elasticity is related to tissue tears.  However, in women, the 
reverse seems to be true .  Perhaps, the structure strength (e.g. collagen cross bridges) is 
also altered by estrogen.  This may explain differences in the results of some studies on 
women versus men.  These knee injuries may be caused by changes in collagen strength 
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not just elasticity.  Estrogen may not only alter ACL elasticity, but may cause a change in 
the breaking strength of the ACL.  Just as bone can fracture due to glycogen crosslinking 
even when it is dense, there may be a similar relationship with collagen in ligaments 
whereby they may tear even if elastic.   This would involve a shift in the force stress 
curve for the ACL making the elastic region shorter and the plastic region larger due to 
estrogen.  There are no studies on structural strength of the ACL in relation to estrogen, 
only elasticity.  It will be interesting to see if there are collagen structure strength changes 
during the menstrual cycle and its relationship to incidence of knee injuries in OCP users 
and non-OCP users.  
We indentified several limationas in the present investigation. Sample size of the 
present study was small.  Moreover, we only examined one full menstrual cycle. 
Although we tested subjects enough times during the menstrual cycle, results may be 
normalized if we examined more than one full menstrual cycle.  Lastly, leg muscle 
temperature should be taken in future studies instead of taking leg skin temperature.  It 
could be powerful evidence to support the relationship between estradiol serum 
concentration and ACL elasticity, FFK, and KFEH and how this relates to tissue 
temperature in young healthy women with a regular menstrual cycle. 
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